GREAT POTENTIAL
On January 28, in the presence of more than 500 guests and long-time partners, PharmaSwiss celebrated 15 years of successful business in Serbia.
The story began in 2000 when PharmaSwiss was established, and since 2011 it has been a part of “Valeant” Canadian pharmaceutical company with the fastest growth in the world.
Two years ago, Canadian “Valeant” built a pharmaceutical factory in Belgrade and it is one of the most modern in this part of Europe. Valeant has invested EUR 30 million in it, being the largest Greenfield investment of this North American company in Serbia. The capacities are 16 million boxes of medications per year.
They currently have 300 employees. A broad portfolio covers all important therapeutic areas, and Dr. Antonic points out that the largest potential is in the area of cardiac medications.